Express Scripts, others fail to pause US FTC in-house insulin pricing suit pending appeal
MLex Summary: Express Scripts and other pharmacy benefit managers failed to convince a US appeals court to preliminarily prohibit an administrative proceeding initiated by the Federal Trade Commission pending an appeal.See...To view the full article, register now.
Already a subscriber? Click here to view full article